Health Policy Podcast
Ross Marchand, executive director of the Taxpayers Protection Alliance, discusses his organization's report Blocking Breakthroughs, which examines FDA drug rejection rates. He said that regulatory barriers, shifting standards, and excessive risk aversion are delaying patient access to potentially life-saving treatments, even as other developed countries approve the same drugs.
23 episoder
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Health Policy Podcast-fællesskabet!